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Abstract Transposable elements (TEs) are mobile geno-
mic sequences of DNA capable of autonomous and non-
autonomous duplication. TEs have been highly successful,
and nearly half of the human genome now consists of various
families of TEs. Originally thought to be non-functional,
these elements have been co-opted by animal genomes to
perform a variety of physiological functions ranging from
TE-derived proteins acting directly in normal biological
functions, to innovations in transcription factor logic and
influence on epigenetic control of gene expression. During
embryonic development, when the genome is epigenetically
reprogrammed and DNA-demethylated, TEs are released
from repression and show embryonic stage-specific
expression, and in human and mouse embryos, intact TE-
derived endogenous viral particles can even be detected. A
similar process occurs during the reprogramming of somatic
cells to pluripotent cells: When the somatic DNA is
demethylated, TEs are released from repression. In embry-
onic stem cells (ESCs), where DNA is hypomethylated, an
elaborate system of epigenetic control is employed to sup-
press TEs, a system that often overlaps with normal epige-
netic control of ESC gene expression. Finally, many long
non-coding RNAs (lncRNAs) involved in normal ESC
function and those assisting or impairing reprogramming
contain multiple TEs in their RNA. These TEs may act as
regulatory units to recruit RNA-binding proteins and epi-
genetic modifiers. This review covers how TEs are inter-
linkedwith the epigeneticmachinery and lncRNAs, and how
these links influence each other tomodulate aspects of ESCs,
embryogenesis, and somatic cell reprogramming.
Keywords Transposable elements  Endogenous
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1 TEs constitute a substantial proportion of the human
genome
Mammalian genomes consist of a surprisingly high content
of TEs. By counting the number of base pairs that appear
within a specific genomic feature, such as a protein-coding
gene, or repeat element, we can estimate that the human
genome consists of approximately 51 % unannotated DNA,
4 % protein-coding genes and other regulatory RNAs, and
nearly 40 % of the genome consists of TEs (Fig. 1). These
numbers are in agreement with previous estimates [1–3]
and reveal how successful TEs have been in propagating
themselves in the human genome. Although TEs occupy
nearly half of the genome, this is still an underestimate
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since computational techniques to detect TEs, such as
RepeatMasker, have limited ability to identify ancient or
divergent TEs. For example, the Xist lncRNA has several
ancient TEs within its RNA that could only be identified
using more sensitive methods [4]. Hence, as more sensitive
techniques become available, and with a better under-
standing of the evolutionary history of genome sequences,
the percent of identified TEs in the genome is likely to rise.
TEs can be classified into four major categories: DNA
transposons and three classes of retrotransposon: long ter-
minal repeat (LTR) containing endogenous retroviruses,
long interspersed nuclear elements (LINEs), and short
interspersed nuclear elements (SINEs) [5–7]. DNA trans-
posons make up the smallest class of TEs (2.9 %; Fig. 1).
The DNA transposons copy themselves by a ‘‘cut-and-
paste’’ mechanism and rely on transposition during S phase
for duplication. DNA transposons do not pass through an
RNA intermediate, unlike the largest class of TEs, the
retrotransposons (37 %; Fig. 1). LTR elements are
endogenous retroviruses, and they are generally non-func-
tional due to the accumulation of genomic mutations,
although 16–18 ERVs are predicted to have a valid coding
sequence for viral envelope proteins [8, 9], and there are
many intact open-reading frames for viral capsids [10].
LINEs are the single largest category of TE (18 %). These
TEs encode their own transposase, an enzyme required for
TE duplication. Although most are non-functional due to
mutation, it is estimated that at least 68 individual LINE-1
insertions are still active in human cells [11]. SINEs
(11 %), conversely, do not encode their own transposase
and instead rely on LINE encoded transposases to duplicate
themselves. Consequently, they have sometimes been
referred to as a ‘‘parasite’s parasite’’ [12].
Originally, TEs were thought to be non-functional,
mainly parasitic elements, plaguing the genome, but there
is a growing body of evidence that demonstrates roles for
TEs in multiple biological processes. The most visible is
the direct co-option (or exaptation) of endogenous retro-
viral genes for biological functions. For example, the
syncytins (ERVWE1 in human, Syna/b in mouse) have
been independently co-opted by evolution for a role in
syncytium formation in the developing placenta [2]. The
RAG1/2 enzymes critical for immunoglobulin V-D-J
recombination in the immune system appear to be derived
from transposases [13], along with several other examples
of the co-option of viral genes for legitimate biological
function [2]. Besides this direct use of the TE genes, evi-
dence suggests that TEs themselves are involved in mul-
tiple aspects of early embryogenesis [14, 15], by forming
regulatory elements to modulate epigenetic control [3],
introduce alternate splice sites, provide evolutionary
innovations in patterns of transcription-factor-binding sites
[16, 17], influence genome evolution [5, 18], and may form
functional regulatory domains in lncRNAs [19]. In this
review we focus on the regulatory connections between
TEs, epigenetics, and lncRNAs, and how these three facets
are intimately linked with each other in the control of
ESCs, reprogramming somatic cells to pluripotent stem
cells, and early embryogenesis.
2 TEs in embryonic development
TE expression has long been documented at various stages
of embryonic development in the mouse [20, 21]. In the
oocyte mRNA pool, a MaLR LTR may comprise up to
13 % of the total mRNA [22], and SINE elements may
comprise a further 2 %–3 % [23]. Intact viral-like particles
had long been observed under the electron microscope in
mouse 2-cell embryos [24]. Still, it came as something of a
shock to find viral-like structures in human embryos [25].
Although the human genome contains many intact open-
reading frames for viral proteins [8–10], and a HERVK can
be induced to from viral particles [26], no intact viral
capsids had previously been observed in human embryos.
These observations, coupled with genomic analysis, has
focused research efforts on attempting to understand what
possible roles these TEs play during early embryonic
development, or whether they are just escaping epigenetic
silencing when the embryonic genome is demethylated and
reprogrammed. Genomic analysis of the RNA complement
of developing embryos has been revealing. Expressed
sequence tag (EST) data indicate the widespread expres-
sion of multiple classes of TEs at different embryonic
Fig. 1 Estimated proportions of various selected genomic features
within the human genome. Annotations were taken from GENCODE
v23 with duplicate exons removed, and the UCSC genome browser
‘‘repeats and variations/rmsk’’ track for the human hg38 (GRCh38.p3)
assembly. Base-pair numbers add up to greater than the sequenced
genome size as some regions of DNA can overlap (e.g., lncRNAs and
TEs, genes and TEs, antisense transcripts, and alternate splice sites).
Consequently, the annotated features are somewhat overestimated and
the unannotated genome underestimated
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stages [22, 27]. This has been elaborated recently by RNA-
seq, which produces millions of short reads that can be
mapped to the genome to more accurately locate TEs. This
new technique has been applied to the analysis of single-
cell RNA-seq data from human and mouse embryos and
has revealed the highly specific expression of different
classes of TE at different stages of human and mouse
embryogenesis [28]. Even TEs within the same family
show embryonic stage-specific expression. For example,
for three LTR family members, LTR14B is restricted to the
zygote, 2-cell and 4-cell stages, while LTR7B is mainly
expressed at the 8-cell stage, and LTR7Y is expressed in
the blastocyst [28].
It remains unclear the biological relevance of TE
expression during early embryonic development, as few
functional studies have been carried out. It is difficult to
know in advance which specific TE to mutate, if the gen-
ome contains several tens or even hundreds of thousand of
individual elements, each with different potential func-
tions. Relatedly, only recently has genome-wide ultra-de-
tailed maps of the temporal and tissue-specific expression
of TEs become available [1, 28, 29]. For functionalizing
TEs, one of the defining studies remains the observation
that when MuERV-L transcripts are depleted from mouse
oocytes, the developmental competence at the 4-cell stage
is impaired [30]. This MuERV-L activity is time critical:
The TE is expressed just 8–10 h after fertilization at the
2-cell stage, and although it is expressed up to the blasto-
cyst stage, inhibition of MuERV-L after the critical 4-cell
stage appears to have little effect on viability. Some clues
to the requirements for TEs during early embryonic
development can come from the experimental manipula-
tion of epigenetic modulators and their effect on TE
expression.
3 TEs and epigenetic control in ESCs and the early
embryo
DNA methylation is thought to be one of the major
methods for somatic cells to suppress erroneous TE
expression [31]. The early embryo undergoes dramatic
epigenetic reorganization as the somatic genome is ‘‘reset,’’
and becomes ready for new rounds of differentiation and
development in a process of near-global DNA demethyla-
tion. The widespread DNA demethylation in the early
embryo consequently releases TEs from suppression and is
a potentially hazardous event as the TEs can induce
germline mutations. There is thus a conflict between the
requirement for the erasure of epigenetic marks in the
reprogrammed embryo and the resulting derepression of
hazardous TEs [31]. Consequently, a widespread array of
epigenetic suppression mechanisms, distinct from DNA
methylation, is active in the early embryo and ESCs, and
these mechanisms act to suppress TE activity. Several
factors have been observed to bind to DNA and to recruit
various epigenetic modifiers to specifically suppress TE
expression [3, 14, 32].
3.1 TRIM28 and epigenetic suppression of TEs
One of the best characterized suppressors of TEs is
TRIM28 (KAP-1/TIF1b). TRIM28-knockout mice show
embryonic lethality at E5.5 [33], and a maternal knockout
of TRIM28 shows highly variable phenotypes, from early
post-implantation lethality to a variety of growth abnor-
malities which result in no live births [34], although attri-
bution of this effect to gene imprinting or TE suppression is
unclear. TRIM28 is also required to maintain the sup-
pression of TEs in ESCs, as the loss of TRIM28 leads to the
deregulation of many TEs, and also developmentally reg-
ulated genes, even if relatively distal from TEs [35].
TRIM28 achieves this repression by recruiting the histone
methyltransferase SETDB1 (ESET), heterochromatin pro-
tein 1 (HP1), and the deacetylase NuRD complex [36–38].
Together this complex achieves silencing of TEs, through
methylation of histone H3K9 [35, 36], and via removal of
the activatory histone acetylation epigenetic mark via the
NuRD complex [36]. TRIM28 itself does not bind directly
to DNA, instead it forms a docking platform for DNA-
binding zinc finger proteins (ZFPs), which bind to TRIM28
through a KRAB (Kruppel-associated box) domain.
TRIM28 has been associated with a series of ZFPs:
ZFP809 [39, 40], YY1 (Yin Yang 1) [41], ZFP819 [42],
and the essential pluripotency factor ZFP42 (Rex1) [43].
This widespread interaction with various ZFPs suggests
some sort of code by which ZFPs suppress specific TEs.
The ZFPs are the single largest family of putative tran-
scription factors [44], and about 50 % of them contain a
KRAB (TRIM28-interacting) domain [44]. The large
number of ZFPs is thought to be a reflection of an evolu-
tionary ‘‘arms race’’ between the TEs and the suppression
machinery, an assertion supported by a correspondence
between the number of TEs and the number of ZFPs in
various vertebrate genomes, suggesting the co-evolution of
TEs and suppressor complexes [45]. Recent work has
highlighted this arms race between ZFPs and TEs, as
shown by the rapid evolution of ZFP91 and ZFP93 to
specifically suppress SVA SINE and L1 LINE elements,
respectively [46]. ZFP91 and ZFP93 show modifications in
their coding sequences in response to the emergence of
these two TEs in primate genomes, 8–12 million years ago
[46]. ZFPs appear to suppress TEs by binding directly to
specific sequences inside the TEs themselves and recruiting
epigenetic modifiers to suppress the TEs. Although not
definitive for the hundreds of KRAB-containing ZFPs,
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among 18 KRAB-containing ZFPs analyzed by ChIP-seq,
16 showed enriched binding to various class-specific TEs
[44]. Remarkably, from ZFP809 ChIP-seq data, the de
novo consensus DNA-binding motif was a near perfect
match to an endogenous retrovirus ‘‘PBS-pro’’ DNA
sequence [40], implying that ZFPs specifically recognize
TEs by binding to relevant sequences of DNA. It seems
likely that the KRAB-containing ZFPs are a family of
transcription factors tasked with specific suppression of
TEs by recruiting TRIM28.
TRIM28 acts as a docking platform for a wide array of
co-repressor molecules ranging from histone methyltrans-
ferases, histone demethyltransferases histone deacetylases
HDAC1, 2, 3, and the DNA methyltransferases DNMT3L
[36, 47]. Protein–protein interaction data for TRIM28 [48]
indicate that TRIM28 is also capable of interacting with
many other potential regulatory proteins (Fig. 2). Among
the TRIM28 interactors, many known functional interac-
tions are present, particularly SETDB1 [36–38], KDM1A
[49], and HDACs [50]. Additionally, TRIM28 can also
interact with other epigenetic modifiers and even with
transcription factors important in specifying cell type. For
example, TRIM28 interacts with OCT4 (Pou5f1) [51], the
master regulator of ESCs, and the early embryo [52].
TRIM28 also interacts with many ZFPs, possibly forming a
regulatory code to identify specific TEs and suppress their
expression [44]. Potentially, TRIM28 acts as more than just
a docking platform for the suppression of TEs, but also
integrates an elaborate regulatory network, targeted on the
suppression of TEs (Fig. 3).
3.2 Alternative histone modifications
for the suppression of TEs
SETDB1 is not the only H3K9 methyltransferase involved
in the suppression of TEs, SUV39H also methylates H3K9
to repress TEs, particularly LINEs [53], as can the H3K9
methyltransferases EHMT2 (G9A) and EHMT1 (GLP)
[54], although their role in silencing IAPs is dispensable
and SETDB1 is dominant [38]. Other histone methylations
are also implicated in TE repression, H4K20me3 loss is
seen on TRIM28 knockdown [35], and knockdown of the
TRIM28/SETDB1 binding partner HNRNPK also results
in loss of H4K20me3 at TEs [55], although H4K20me3 is
not thought to be involved in the suppression of IAP TEs
[38]. Loss of the histone H3K4 demethylase KDM1A
(LSD1) also leads to up-regulation of repressed TEs by
indirectly leading to inappropriate deposition of the acti-
vatory H3K4me3 and H3K27ac marks around TEs [49].
Intriguingly, co-immunoprecipitation of KDM1A identified
a complex consisting of much of the CoREST complex
(RCOR1, RCOR2, HDAC1, HDAC2, ZMYM2, PHF21A,
HMG20B, and ZNF217) [50, 56], and additionally
TRIM28 [49]. The presence of the CoREST complex and
HDACs is interesting, suggesting they are deactylating
TEs, which was supported as treatment of ESCs with
Fig. 2 (Color online) TRIM28 is a binding platform for ZFPs and co-repressor/activator molecules protein–protein interaction data for TRIM28
(from BioGRID [48]). The Network shows selected first-degree interactions with TRIM28
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HDAC inhibitors increases the expression of MERVL-
family TEs [49].
3.3 Alternative mechanisms for the suppression of TEs
TRIM28 is not the only regulator of TEs, and other alter-
native mechanisms are also involved. For example, APO-
BEC3B a cytidine deaminase RNA-editing enzyme is
capable of suppressing the expression of LINE1 elements
[57], elements that are active during the early phases of
embryogenesis [58]. RYBP can also suppress TEs [59],
possibly by recruiting the polycomb group repressors
(PRC1, PRC2) via YY1 [60], and knocking out members of
PRC1 or PRC2 results in the upregulation of MLV
endogenous retroviruses [61]. Histone H3 can be replaced
by the variant histone H3.3, the loss of which leads to the
inappropriate derepression of IAP family LTRs in a process
linked with H3K9me3 deposition [62] and so possibly
TRIM28. When the chromatin-remodeling enzyme HELLS
(LSH, a SNF2-like family member) is knocked out, it is
embryonic lethal, and TEs show extensive DNA
demethylation [63]. In addition to epigenetic control of
TEs, RNA interference (RNAi) is also involved, as
knocking down Dicer1 in early embryos leads to an up-
regulation of MuERV-L at the 2-cell stage and IAPs at the
8-cell and blastocyst stages [64]. Similarly, Dicer1-
knockout ESCs showed enhanced transcription from TEs,
particularly IAP and LINE L1 elements [65]. RNAi and
other small RNAs, such as piRNAs, have been proposed as
‘‘guardians of the genome’’ and play critical roles in
maintaining the suppression of various families of TEs in
embryonic and somatic tissues [66].
3.4 Multiple epigenetic signatures and the control
of TE suppression
It is clear that different types of TEs in ESCs harbor
multiple distinct signatures of epigenetic modifications,
i.e., specific combinations of the presence or absence of
H3K4me3, H3K9me3, H4K20me3, and H3K36me3.
Intriguingly, these histone-specific patterns are not only
specific for TE families, but also show both cell-type-and
family-type-specific signatures [67], indicating TE family-
specific control of TE repression, even in somatic cells in
which DNA methylation is thought to be the dominant
suppressive mechanism [31]. Unfortunately, sequence
reads mapping to multiple genomic sites (typically TEs)
are often discarded early in ChIP-seq analysis pipelines,
and consequently, the contribution of epigenetics and
transcription factor binding to TE regulation remains
woefully underestimated.
Ultimately, DNA methylation must be re-established in
somatic tissues for the long-term stability of the genome.
For example, DNMT1-null mice die around E9.5 and show
50- to 100-fold elevated levels of IAP RNA [68]. The
KRAB-ZFPs are involved in the recruitment of the DNA
methyltransferase enzymes [69] and may possibly help in
reestablishing DNA methylation. It seems the global loss of
DNA methylation in the early embryo has led to, or is at
least concomitant with, the evolution of a system of elab-
orate epigenetic control in the early embryo (and in ESCs)
[70], whose primary function is related to the careful
repression of TEs and has a secondary role in controlling
cellular differentiation and development. Ultimately, mul-
tiple overlapping mechanisms of epigenetic silencing are
required to strictly control TE expression during early
embryogenesis when the genome is being reprogrammed
(Fig. 3).
4 TEs in cell fate transitions and reprogramming
somatic cells to pluripotent stem cells
Much in the same way that reprogramming of the embry-
onic genome releases the repression of TEs, something
analogous happens as somatic cells are reprogrammed to
induced pluripotent stem cells (iPSCs). LINE1 TEs are
activated during reprogramming [71], along with many
other families of TE in both mouse- and human-repro-
gramming experiments [72]. The functional role (if any) of
this global derepression of TEs in pluripotent cell repro-
gramming remains unclear. Some clues can be gained by
Fig. 3 (Color online) Model of epigenetic suppression of transpos-
able elements. KRAB-containing ZFPs are recruited to transposable
elements, which then recruits the docking platform TRIM28 protein.
This complex then recruits various co-repressor complexes, including
(but not limited to) DNMTs, CoREST, SETDB1, PRC1, PRC2,
HDACs, and NuRD. Other non-KRAB C2H2 ZFPs may also recruit
co-repressors to TEs, particularly RYBP and YY1. These actions
result in the gain of the repressive histone marks H3K27me3 and
H3K9me3, the gain of variant histone H3.3 and DNA methylation to
silence expression, along with the loss of the activatory H3K4me3
and Histone acetylation. Ultimately, many more epigenetic repressive
mechanisms are likely to be involved in the suppression of TEs
1726 Sci. Bull. (2015) 60(20):1722–1733
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looking at the effect of knocking down epigenetic modifi-
cation enzymes in reprogramming and ESCs. There are
several studies showing that reducing the level of epige-
netic factors can promote reprogramming, while knock-
down of the same factors in ESCs causes the cells to
become unstable and tend to differentiate. For example,
knockdown of KDM1A (LSD1) enhances reprogramming
[73], but its knockdown in ESCs promotes differentiation
[74] via modulation of CoREST and HDAC activity [50]
and grants ESCs an extra capability to differentiate toward
an extraembryonic endoderm-like cell fate [49]. Similarly,
inhibition of HDACs helps in reprogramming [75], while
their inhibition in ESCs results in the up-regulation of TEs
[49] and differentiation [76]. H3K9me3 itself is a major
impediment in reprogramming somatic cells to pluripo-
tency, leading to incompletely reprogrammed ‘‘pre-
iPSCs.’’ These ‘‘pre-iPSCs’’ cells can be converted to fully
reprogrammed iPSCs by using vitamin C [77], a process
that is dramatically enhanced by knocking down H3K9
methyltransferases (and particularly SETDB1) [78]. This
suggests that, cryptically, epigenetic remodeling and the
derepression of TEs are linked and are both involved in cell
fate transitions.
Intriguingly, the expression of a MuERV-L endogenous
retrovirus marks out a very small population of ESCs that
show similarity to the 2-cell stage of the developing
embryo, and these cells have limited totipotent capability
[79]. This process has been linked to the activity of the
chromatin assembly factor 1 (CAF-1) complex, composed
of Chaf1a (p150), Chaf1b (p60), and Rbbp4, which is
involved in the correct deposition of histones H3 and H4
and assembly of heterochromatin. Loss of CAF-1 activity
led to a substantial increase in the numbers of these 2C-like
cells [80]. It is possible that the generation of these 2C-like
cells is related to the extensive changes in heterochromatin
seen in the transition from 2-cell embryos to cells of the
blastocyst, a reorganization not observed in Chaf1a-mutant
embryos [81].
The activation of TEs during reprogramming is of some
concern as they have the potential to mutate the genome
and so render patient-specific pluripotent cells oncogenic.
Increased variability in the activity of TEs has been
observed in different iPSC lines [72]. The release of TE
suppression by deletion of the variant H3.3, which is
associated with the repressive histone modification
H3K9me3, leads to increased levels of chromosomal
abnormalities [62]. An otherwise normal ESC line that had
lost suppression of ERVs became incapable of germline
transmission and resulted in chimeric mice with a charac-
teristic ‘‘kinky tail’’ phenotype [82], that is reminiscent of
phenotypes observed in mice with defects related to DNA
methylation at LTRs. These results suggest that TE
silencing is required for correct maintenance of
pluripotency and chimera generation. It remains unclear
whether the derepression of TEs is an absolutely essential
event in somatic cell reprogramming or simply a side effect
of global DNA demethylation. DNA demethylation itself is
an essential requirement for the mesenchymal-to-epithelial
transition (MET) [83], a critical event that occurs very
early in the reprogramming process [84]. Knockouts of the
three TET enzymes responsible for DNA demethylation
leads to a block in the MET, and consequently repro-
gramming is also impaired [83]. Strategies to accelerate
reprogramming [77, 85] are thus extremely valuable as
they may help to minimize the window when TEs are
active and capable of modifying the genome.
5 TEs are lncRNAs, and lncRNAs are TEs
Long noncoding RNAs (lncRNAs) are a class of gene that
lack an obvious coding sequence, yet show many of the
hallmarks of coding sequence genes, such as alternate
splicing, and evolutionary conservation [86]. LncRNAs
contain substantial components of TEs: 83 % of lncRNAs
contain at least one TE, while of the total number of base
pairs that comprise lncRNA sequences, 42 % is derived
from TEs [87, 88]. Conversely, only 6 % of coding genes
overlap with TEs [87, 88]. LncRNAs instead seem to
match more closely to the genomic frequencies of TEs,
albeit lncRNAs are depleted for particular classes of TE,
such as L1 and enriched for others, such as MIR [87].
Several lncRNAs have been implicated as critical for ESC
function and simultaneously are made of TEs. LINC-ROR,
which modulates the efficiency of reprogramming [89],
consists almost entirely of TEs (Fig. 4a), its transcription
start site begins inside a HERVH element, and the LINC-
ROR RNA contains further MLTIJ, L3, MIR, and other
elements, while the introns contain multiple further MIR
and Alu and other TEs [87]. LINC-ROR acts as a ‘‘sponge’’
to block the miRNA-mediated degradation of the critical
pluripotency factors OCT4, SOX2, and NANOG [90]; of
the five predicted miRNA-binding sites, four are within a
TE including both of the experimentally confirmed
miRNA-145-binding sites. LINC01108 (Linc-ES3) is
required to maintain pluripotency [91] and contains two
TEs (Fig. 4a). The mouse Trp53cor1 (lncRNA-p21), which
is deleterious for reprogramming iPSCs [92], contains 7
TEs (Fig. 4b). LncRNAs can interact directly with the
pluripotency machinery: Human L1TD1 is a lncRNA
required to maintain pluripotency that is derived from the
open-reading frame 1 of a LINE L1. It is capable of
interacting with the pluripotency factor and RNA-binding
protein LIN28A to modulate the levels of the pluripotent
master regulator OCT4 [93], although L1TD1 is dispens-
able in mouse [94]. Genome-wide single-cell gene
Sci. Bull. (2015) 60(20):1722–1733 1727
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Fig. 4 Genomic views of selected lncRNAs with demonstrated involvement in reprogramming or ESC maintenance reveal extensive presence of
TEs. Genomic views indicate the gene; thick black parts indicate exons, which are connected with thin lines (introns). TEs are indicated across
three lines in the gray panel, the top (red) indicates LTR endogenous retroviruses, the middle (green) indicates SINEs, and the bottom (blue)
indicates LINEs. TEs above the light gray line are on the positive DNA strand and TEs below the light gray line are on the negative DNA strand.
Some duplicate TE labels were removed for clarity. a LncRNAs involved in human iPSC reprogramming, LINC-ROR [89], and LINC01108
(linc-ES3) [91]. b Two mouse lncRNAs involved in reprogramming: Trp53cor1 (lincRNA-p21) [92] and 4930500J02Rik (Ladr83) [95]. c A
selected series of lncRNAs involved in the maintenance of mouse ESCs [96]: Cnrde/Gm21817 (Linc1399), 1500009L16Rik (Linc1435),
B230206L02Rik (Linc1448), 4933404O12Rik (Linc1543), Halr1 (Linc1547), 2500002B13Rik (Linc1577), and Lincenc1 (Linc1283). d The
critical pluripotency gene Pou5f1 is shown for comparison. The protein-coding sequence is indicated with a thicker black line within the exons.
Mouse genomic coordinates are mm10 and human are hg38 assemblies
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expression has revealed the widespread modulation of
lncRNAs during reprogramming [95], and two lncRNAs in
particular were identified as important in the reprogram-
ming process: Gm16096 (Ladr49) and 4930500J02Rik
(Ladr83), both of which contain TEs (Fig. 4b). This pattern
extends for many other lncRNAs involved in the mainte-
nance of the ESC state (Fig. 4c) [96]. However, as an
example, the critical pluripotency gene Pou5f1 avoids any
TEs inside its exons (Fig. 4d), although Nanog does con-
tain SINE elements in its 30UTR in both human and mouse.
An important caveat must be applied to research on TEs
and lncRNAs. Experiments that use RNAi to knockdown
entire classes of TE need to take some care as the RNAi
may inadvertently also knockdown lncRNAs carrying the
same TE that are essential for the maintenance of the
pluripotent state. For example, HERVH-containing RNAs
are specifically expressed in hESCs [97], are required for
pluripotency [98], and, within the DNA, provide tran-
scription-factor-binding sites for the naı¨ve-specific LBP9
(also called Tfcp2l1) transcription factor [99]. Disruption
of either LBP9, HERVH, or even HERVH-derived tran-
scripts (novel RNAs derived from HERVH transcripts,
some labeled as lncRNAs) led to the loss of pluripotency
[99], yet LINC-ROR contains parts of a HERVH, and it is
likely many other as yet undiscovered lncRNAs important
for pluripotency also contain HERVH sequences. Conse-
quently, knocking down the entire class of HERVHs in
ESCs has the potential to also hit HERVH-containing
lncRNAs that are essential for pluripotency.
It is a curious observation that many pluripotency-re-
lated lncRNAs begin their expression from a TE-derived
promoter [88]. One possible explanation is that these TE-
derived promoters may lead to the genesis of lncRNAs,
starting from a TE-derived promoter and building up to a
full lncRNA as new regulatory units and exons are
assembled into a functional lncRNA. It remains unclear
whether the lncRNA comes first, and then TEs colonize the
functional lncRNA or instead TEs come first and assemble
into a functional lncRNA [88]. Overall, it is clear that TE-
containing lncRNAs play critical roles in the maintenance
of pluripotency and the generation of iPSCs.
As TEs are often embedded in lncRNAs, this leads to
the consequence that the literature discussing the biological
functions of lncRNAs can also be considered as addressing
potential regulatory or biological functions of TEs. It
remains unclear exactly where TE expression ends and
lncRNAs begin, and it is possible that researchers mapping
the expression of TEs, using RepeatMasker TE annota-
tions, may inadvertently be mapping lncRNAs, and calling
them TE expression, while similarly, researchers de novo
assembling RNA-seq data into novel transcripts may be
assembling units of TE expression and calling them
lncRNAs [100]. In that study, of the 3692 unannotated
assembled transcripts, only 44 had robust expression and a
predicted protein domain, the rest were unannotated tran-
scripts that were enriched for various classes of TE [100].
The relationship between lncRNAs and TEs will need to be
clearly defined as more RNA-seq datasets and better gen-
ome annotations become available [86].
5.1 LncRNAs and regulation of chromatin modifiers
It is intriguing that lncRNAs physically interact with
chromatin modifiers, particularly the H3K27 and H3K9
methyltransferases [96]. Considering these are the same
enzymes responsible for suppressing TE expression [53,
54, 61], it is possible that the TEs role in modulating
chromatin silencing for their own benefit has been co-opted
by lncRNAs and used to control normal developmental
programs. Indeed, lncRNA-p21 interacts with the H3K9
methyltransferase SETDB1 and the DNA methyltrans-
ferase DNMT1 during reprogramming to suppress
pluripotency-related genes [92]. The binding of lincRNA-
p21 to SETDB1 is mediated by HNRNPK, in a complex
that can also specifically suppress TEs in ESCs [55]. That
lncRNAs can recruit epigenetic modifiers is not unique to
lncRNA-p21, and HOTAIR can recruit the PRC2 complex
to methylate H3K27 and suppress gene expression at the
HOX locus [101]. HERVH RNA in human ESCs can form
scaffolds for the recruitment of co-activator complexes,
particularly CBP, p300, MED6, MED12, OCT4, and
CDK8, and HERVH expression is required both to estab-
lish the pluripotent state and to maintain it [98, 99]. The
dynamic changes in lncRNAs observed during repro-
gramming [95] may also be related to the widespread
epigenetic derepression of TEs during reprogramming [72].
For example, when KDM1A, an important enzyme for TE
suppression, is knocked down in human somatic cells, they
show enhanced reprogramming capability [73]. Similarly,
a KDM1A inhibitor is included in the cocktail of molecules
that can reprogram mouse somatic cells to pluripotent cells
[102]. This suggests epigenetic control of reprogramming
is also interconnected with mechanisms of TE suppression,
although it remains unclear whether this beneficial effect
on reprogramming is related to the derepression of TEs, or
some other epigenetic process carried out by KDM1A
during reprogramming.
5.2 TEs as regulatory modules in lncRNAs
Although TEs are relatively rare in protein-coding genes
[87, 88], they do show some bias toward the untranslated
terminal region (UTR) of the mRNA [1]. This hints at a
link to RNA-binding proteins and other levels of mRNA
regulation. It is already known that the double-stranded
RNA-binding protein Staufen (Stau1) can bind to an Alu–
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Alu stem loop to induce RNA degradation [103]. Relat-
edly, a systematic analysis of lncRNAs predicted TE-
containing lncRNAs are more stable than non-TE-con-
taining lncRNAs [88], suggesting a general role for TEs in
modulating lncRNA degradation. Alu elements have also
been demonstrated as critical for APTR-mediated sup-
pression of the CDKN1A promoter by recruiting polycomb
proteins to suppress its expression [104]. For other TE
classes, a SINE element in the neuron-specific Uchl1
mRNA is required for posttranscriptional up-regulation
[105]. It is not inconceivable that other TEs in protein
coding or lncRNAs could serve as targets for RNA-bind-
ing-mediated regulation. HERVH RNA in hESCs is pre-
dicted to form a common domain that may potentially bind
to other proteins, particularly pluripotent transcription
factors [99]. It is possible to imagine that TEs residing
inside lncRNAs act as regulatory elements for RNA-
binding proteins, much in the same way that TEs in the
genome harbor transcription-factor-binding sites [17]. The
idea that TEs can form regulatory ‘‘domains’’ in lncRNAs
has been expounded in the Repeat Insertion Domains of
LncRNAs (RIDL) hypothesis [19], which posits that TEs
form the regulatory modules inside lncRNAs, in an anal-
ogous fashion to structural domains in proteins. These
domains can be swapped and exchanged between lncRNAs
to innovate new biological functions [19]. This attractive
hypothesis awaits validation, although many encouraging
observations have been made. For example, a meta-anal-
ysis of RNA-binding protein CLIP-seq data uncovered
extensive targeting of RNA-binding proteins to TEs [106].
Intriguingly, TEs can also act the other way around, as
functional RNA-binding proteins themselves. For example,
ESCs specifically express endogenous retrovirus HERVK
[107], and a HERVK Rec protein can bind to the mRNAs
of a wide array of signaling receptors (FGFR1, FGFR3,
FGFR13, GDF3, and FZD7), chromatin modifiers
(DNMT1, CHD4), and other RNA-binding proteins
(LIN28A) important for pluripotency [25].
6 The expanding links between TEs, lncRNAs,
epigenetics, and embryogenesis
The links between lncRNAs, epigenetics, and embryoge-
nesis are likely to grow in the future. The embryo, with its
capability for germline transmission, is the site of vigorous
competition between TEs and the host epigenetic sup-
pression machinery as TEs vie to propagate their own DNA
through the germ line. This vigorous competition has led to
the co-option of TEs (perhaps as lncRNAs) and also the co-
option of TE-mediated modulation of epigenetic regulation
in normal developmental processes. Although an overar-
ching model linking TEs, lncRNAs, and epigenetics
remains lacking, and new data must be collected, it seems
likely that the deep interconnection of TEs, lncRNAs, and
embryogenesis will take yet more unexpected turns as
surprising new observations emerge. As this review was
going to press, an important study was published that
systematically interrogated the factors in ESCs that are
required for silencing of ERVs [108]. Using a genome-
wide knockdown screen Yang and colleagues discovered
hitherto unknown factors critical for the silencing of ERVs,
particularly histone chaperones, alternate chromatin mod-
ifiers and intriguingly the sumoylation system. This study
provides an excellent resource for the further study of TEs
and provides many novel candidate mechanisms involved
in the suppression of TEs.
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